ANIX Anixa Biosciences, Inc.
Healthcare$2.73-2.15%ClosedMarket Cap: $91.5M
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$5.83
Target (Median)
$4.00
Target Range
$3.50 - $10.00
Upside from current price: 113.6%
Rating Distribution
1 Strong Buy3 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-04-08 | D. Boral Capital | maintain | Buy | Buy |
| 2026-02-04 | D. Boral Capital | maintain | Buy | Buy |
| 2025-12-12 | D. Boral Capital | maintain | Buy | Buy |
| 2025-10-07 | D. Boral Capital | maintain | Buy | Buy |
| 2025-09-11 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-08-19 | D. Boral Capital | maintain | Buy | Buy |
| 2025-06-10 | D. Boral Capital | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Sun Oct 31 | $-0.31 | $34.0M | 1 |
| Tue Oct 31 | $-0.33 | $0.00 | 2 |
| Wed Oct 31 | $-0.19 | $22.6M | 1 |
| Thu Oct 31 | $1.10 | $72.4M | 1 |